Drug
Amoxicillin Clavulanate Postassium
Amoxicillin Clavulanate Postassium: highest development phase Phase 1, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL NCT00840099 | Phase 1 | Healthy |
Latest
No recent events.
Follow Amoxicillin Clavulanate Postassium on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.